Guardian Pharmacy Services, Inc. (GRDN) — Financial statements
Income statement, balance sheet, and cash flow for Guardian Pharmacy Services, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,449↑17.9% | 1,228↑17.4% | 1,046↑15.1% | 909↑14.8% | 792 | |
| Cost of Revenue | 1,167↑18.6% | 984↑17.4% | 838↑15.9% | 723↑14.6% | 631 | |
| Gross Profit | 282↑15.4% | 244↑17.3% | 208↑12.1% | 186↑15.3% | 161 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00↑100.0% | -3↓125.9% | 13 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00↓100.0% | 137↑16.2% | 118 | |
| SG&A Expenses | 193↓37.2% | 307↑83.6% | 167↑25.0% | 134↑2.1% | 131 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 193↓37.2% | 307↑83.6% | 167↑25.0% | 134↑2.1% | 131 | |
| Total Costs & Expenses | 1,360↑5.3% | 1,291↑28.5% | 1,005↑17.3% | 857↑12.5% | 762 | |
| Operating Results | ||||||
| Operating Income | 89↑241.3% | -63↓253.7% | 41↓21.2% | 52↑72.4% | 30 | |
| Depreciation & Amortization | 22↑13.0% | 20↑8.4% | 18↑10.1% | 17↑0.2% | 17 | |
| EBITDA | 111↑356.2% | -43↓173.8% | 59↓13.7% | 68↑46.6% | 46 | |
| EBIT | 89↑240.7% | -63↓255.7% | 41↓21.3% | 52↑72.2% | 30 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.67↑79.7% | -3↓14.7% | -3↓48.4% | -2↓17.7% | -2 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.67↓79.7% | 3↑14.7% | 3↑48.4% | 2↑17.7% | 2 | |
| Non-Operating Income | 0.00↓100.0% | 0.28↓24.0% | 0.37↓8.9% | 0.40↑115.5% | 0.19 | |
| Other Income / Expenses | -15↓335.5% | -4↓10.3% | -3↓38.5% | -2↓27.7% | -2 | |
| Income Before Tax | 73↑210.4% | -66↓276.2% | 38↓24.0% | 50↑75.3% | 28 | |
| Income Tax Expense | 24↑437.0% | 5 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 49↑168.9% | -71↓288.3% | 38↓24.0% | 50↑75.3% | 28 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 49↑156.4% | -87↓465.2% | 24↓32.5% | 35↑117.1% | 16 | |
| Bottom-Line Net Income | 49↑144.7% | -110↓560.4% | 24↓32.5% | 35↑117.1% | 16 | |
| EPS (Basic) | 0.79↑144.6% | -1.77↓553.8% | 0.39↓32.8% | 0.58↑114.8% | 0.27 | |
| EPS (Diluted) | 0.78↑144.1% | -1.77↓553.8% | 0.39↓32.8% | 0.58↑114.8% | 0.27 | |
| Weighted Average Shares | 62↑0.6% | 62↑1.9% | 61↑0.0% | 61↑0.0% | 61 | |
| Weighted Average Diluted Shares | 63↑2.1% | 62↑1.9% | 61↑0.0% | 61↑0.0% | 61 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.